One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum

Journal of Immunological Methods

Volumn 307, Issue 1-2, 2005, Pages 1-12

  Fernández Sánchez, César ^a,d   McNeil, Calum J ^a   Rawson, Keith ^b   Nilsson, Olle ^c   Leung, Hing Y ^a   Gnanapragasam, Vincent ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Cambridge Life Sciences Ltd   (United Kingdom)

^c Fujirebio Diagnostics Inc   (Sweden)

^d INSTITUTO DE MICROELECTRÓNICA DE BARCELONA   (Spain)

Author keywords

Colloidal gold; Free and total prostate specific antigen; Immunostrip; Lateral flow assay; Serum

Indexed keywords

COLLOIDAL GOLD; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CALIBRATION; CANCER DIAGNOSIS; COLOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN IMMOBILIZATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SHELF LIFE;

ANTIBODIES, MONOCLONAL; CALIBRATION; GOLD COLLOID; HUMANS; IMMUNOASSAY; LINEAR MODELS; MALE; MEMBRANES, ARTIFICIAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REAGENT STRIPS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 29144524683     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.08.014     Document Type: Article

References (34)

1. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 327 1986 307
2. J.M. Bland, and D.G. Altman Measuring agreement in method comparison studies Stat. Methods Med. Res. 8 1999 135
3. M.K. Brawer Screening for prostate cancer Sem. Surg. Oncol. 18 2000 29
4. S. Bührer-Sekula, F.F.V. Hamerlinck, T.A. Out, L.G. Bordewijk, and P.R. Klatser Simple dipstick assay for semi-quantitative detection of neopterin in sera J. Immunol. Methods 238 2000 55
5. W.J. Catalona, D.S. Smith, R.L. Wolfert, T.J. Wang, H.G. Rittenhouse, T.L. Ratliff, and R.B. Nadler Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening JAMA 274 1995 1214
6. W.J. Catalona, A.W. Partin, K.M. Slawin, M.K. Brawer, R.C. Flanigan, A. Patel, J.P. Richie, J.B. deKernion, P.C. Walsh, P.T. Scardino, P.H. Lange, E.N.P. Subong, R.E. Parson, G.H. Gasior, K.G. Loveland, and P.C. Southwick Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial JAMA 279 1998 1542
7. C.P.Y. Chan, K.W. Sum, K.Y. Cheung, J.F.C. Glatz, J.E. Sanderson, A. Hempel, M. Lehmann, I. Renneberg, and R. Renneberg Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein J. Immunol. Methods 279 2003 91
8. C.D. Cheli, M. Marcus, J. Levine, M. Zhou, P.H. Anderson, D.D. Bankson, J. Bock, S. Bodin, C. Eisen, M. Senior, M.K. Schwartz, K.K. Yeun, and W.J. Allard Variations in the quantitation of prostate specific antigen in reference materials: differences in commercial immunoassays Clin. Chem. 44 1998 1551
9. C. Fernández-Sánchez, A.M. Gallardo-Soto, K. Rawson, O. Nilsson, and C.J. McNeil Quantitative impedimetric immunosensor for free and total prostate specific antigen based on a lateral flow assay format Electrochem. Commun. 6 2004 138
10. C. Fernández-Sánchez, C.J. McNeil, K. Rawson, and O. Nilsson Disposable non-competitive immunosensor for free and total prostate-specific antigen based on capacitance measurement Anal. Chem. 76 2004 5649
11. M. Han, P.H. Gann, and W.J. Catalona Prostate-specific antigen and screening for prostate cancer Med. Clin. North Am. 88 2004 245
12. K. Jung, Z. Jürgen, M. Lein, B. Brux, P. Sinha, S. Lenk, D. Schnorr, and S.A. Loening Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests compared Urology 53 1999 155
13. G. Karazanashvili, and P.-A. Abrahamsson Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer J. Urol. 169 2003 445
14. M. Kuriyama, M.C. Wang, L.D. Papsidero, C.S. Killian, T. Shimano, L. Valenzuela, T. Nishiura, G.P. Murphy, and T.M. Chu Quantitation of prostate-specific antigen in serum by a sensitive enzyme-immunoassay Cancer Res. 40 1980 4568
15. J.H. Lee, K.S. Hwang, J. Park, K.H. Yoon, D.S. Yoon, and T.S. Kim Immunoassay of prostate-specific antigen (PSA) using resonant frequency shift of piezoelectric nanomechanical microcantilever Biosens. Bioelectron. 20 2005 2157
16. M. Lein, K. Jung, D. Schnorr, W. Henke, and S.A. Loening Strip test for the quick detection of increased concentrations of prostate specific antigen in blood Eur. J. Clin. Chem. Clin. Biochem. 34 1996 511
17. W. Leung, P. Chan, F. Bosgoed, K. Lehmann, I. Renneberg, M. Lehmann, and R. Renneberg One-step quantitative cortisol dipstick with proportional reading J. Immunol. Methods 281 2003 109
18. H. Lilja, A. Christensson, U. Dahlén, M.T. Matikainen, O. Nilsson, K. Petersson, and T. Lövgren Prostate-specific antigen in serum occurs predominantly in complex with a1-antichymotrypsin Clin. Chem. 37 1991 1618
19. Long, N.D., Pearson, M.T., Rawson, K., 2002. Assay apparatus. World Patent WO 02/010754.
20. S. Madersbacher, C. Mian, U. Maier, and R. Simak Validation of a 10-minute dipstick test for serum prostate-specific antigen Eur. Urol. 30 1996 446
21. A. Milford Ward, J.W.F. Catto, and F.C. Hamdy Prostate specific antigen: biology, biochemistry and available commercial assays Ann. Clin. Biochem. 38 2001 633
22. M. Müller-Bardoff, T. Rauscher, M. Kampmann, S. Schoolmann, F. Laufenberg, D. Mangold, R. Zerback, A. Remppis, and H.A. Katus Quantitative bedside assay for cardiac troponin T: a complementary method to centralized laboratory testing Clin. Chem. 45 1999 1002
23. O. Nilsson, A. Peter, I. Andersson, K. Nilsson, B. Grundstrom, and B. Karlsson Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA Br. J. Cancer 75 1997 789
24. M. O'Keeffe, P. Crabbe, M. Salden, J. Wichers, C. Van Peteghem, F. Kohen, G. Pieraccini, and G. Moneti Preliminary evaluation of a lateral flow immunoassay device for screening urine samples for the presence of sulphamethazine J. Immunol. Methods 278 2003 117
25. P.M. O'Neill, J.E. Fletcher, C.G. Stafford, P.B. Daniels, and T. Bacerese-Hamilton Use of an optical biosensor to measure prostate-specific antigen in whole blood Sens. Actuators, B 29 1995 79
26. F. Oberpenning, S. Hetzel, C. Weining, B. Brandt, G. De Angelis, A. Heinecke, M. Lein, P. Fornara, H.P. Schmid, L. Hertle, and A. Semjonow Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer? Eur. Urol. 43 2003 478
27. T.J. Polascik, J.E. Oesterling, and A.W. Partin Prostate specific antigen: a decade of discovery-what we have learned and where we are going J. Urol. 162 1999 293
28. B. Rafferty, P. Rigsby, M. Rose, T. Stamey, and R.G. Das Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10) Clin. Chem. 46 2000 1310
29. P. Sarkar, P.S. Pal, D. Ghosh, S.J. Setford, and I.E. Tothill Amperometric biosensors for detection of the prostate cancer marker (PSA) Int. J. Pharm. 238 2002 1
30. D.R. Thévenot, K. Toth, R.A. Durst, and G.S. Wilson Electrochemical biosensors: recommended definitions and classification Biosens. Bioelectron. 16 2001 121
31. R.W. Veltri, and M.C. Miller Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations Urology 53 1999 736
32. R. Verheijen, P. Stouten, G. Cazemier, and W. Haasnot Development of a one strip test for the detection of sulfadimidine residues Analyst 123 1998 2437
33. WHO World Health Report http://www.who.int/whr/2004 2004
34. Wu, G. Datar, R.H., Hansen, K.M., Thundat, T., Cote, R.J., Majumdar, A., Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat. Biotech. 19, 856-860.